Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_assertion type Assertion NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_head.
- NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_assertion description "[Using conditional logistic regression, the authors compared per-allele odds ratios for prostate cancer for 39 GWAS-identified SNPs across thirds (tertile groups) of circulating concentrations of insulin-like growth factor 1 (IGF-1), insulin-like growth factor binding protein 3 (IGFBP-3), testosterone, androstenedione, androstanediol glucuronide, estradiol, and sex hormone-binding globulin (SHBG) for 3,043 cases and 3,478 controls in the Breast and Prostate Cancer Cohort Consortium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_provenance.
- NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_assertion evidence source_evidence_literature NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_provenance.
- NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_assertion SIO_000772 22459122 NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_provenance.
- NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_assertion wasDerivedFrom befree-2016 NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_provenance.
- NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_assertion wasGeneratedBy ECO_0000203 NP971124.RASyTMgqTLP_REbZTQlwHqFaqsIiC_-EmmidH8awQMy2g130_provenance.